83 completed, 7 terminated, 1 active not recruiting, 1 recruiting. 93 Phase 1, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 93 | Completed 83, Terminated 7, Active not recruiting 1, Recruiting 1, Withdrawn 1 |
| Phase 2 | 4 | Terminated 3, Completed 1 |
Follow Ketoconazole: new trials by email Literature Review of Ketoconazole trials Research Report on Ketoconazole
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ketoconazole Effects on the Daily Cortisol Rhythm in Mild Autonomous Cortisol Secretion Ketoconazole - Mild Autonomous Cortisol Secretion | Phase 1 | Recruiting | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 36 | 2026-07-27 | 2026-08-31 |
| Bioavailability of Levoketoconazole and Ketoconazole Tablets Levoketoconazole, Ketoconazole - Healthy | Phase 1 | Completed | Cortendo AB | 34 | 2019-12-16 | 2020-01-31 |
| Hormonal Mechanisms of Sleep Restriction - Axis Study Ketoconazole Pill, Ganirelix, Dexamethasone - Sleep Restriction | Phase 1 | Active not recruiting | Peter y. Liu | 80 | 2017-05-08 | 2025-09-11 |
| Fenretinide Lym-X-Sorb + Ketoconazole + Vincristine for Recurrent or Resistant Neuroblastoma Fenretinide/LXS Oral Powder, Ketoconazole, Vincristine - Recurrent Neuroblastoma, Neuroblastoma | Phase 1 | Terminated | South Plains Oncology Consortium | 4 | 2014-05-01 | 2022-03-31 |
| A Study to Assess the Effect of Ketoconazole on the Metabolism of ABT-199 ABT-199, Ketoconazole - Non-Hodgkin's Lymphoma | Phase 1 | Completed | AbbVie | 12 | 2013-12-01 | 2017-11-20 |
| A Pharmacokinetics Study to Investigate the Effect of Ketoconazole on Vemurafenib in Patients With BRAFV600 Mutation-Positive Metastatic Melanoma ketoconazole, vemurafenib - Malignant Melanoma, Neoplasms | Phase 1 | Withdrawn | Hoffmann-La Roche | 2013-10-01 | 2016-11-02 | |
| Effect of Ketoconazole on the Pharmacokinetics of Refametinib BAY86-9766, Ketoconazole - Drug Interactions | Phase 1 | Completed | Bayer | 18 | 2013-09-01 | 2014-01-08 |
| A Study of Baricitinib When Administered With Ketoconazole or Fluconazole in Healthy Participants Baricitinib, Ketoconazole, Fluconazole - Healthy Volunteers | Phase 1 | Completed | Eli Lilly and Company | 36 | 2013-08-01 | 2017-06-06 |
| Study to Assess the Effect of Ketoconazole on the Pharmacokinetics of NBI-98854 in Healthy Subjects NBI-98854 50 mg capsule once daily, Ketoconazole 400 mg (200 mg twice daily) - Effect of Ketoconazole on the PK of NBI-98854 in Healthy Subjects | Phase 1 | Completed | Neurocrine Biosciences | 24 | 2013-07-01 | 2013-09-05 |
| CC-223 and Ketoconazole Drug-Drug Interaction Study CC-223, Ketoconazole - Healthy Volunteers | Phase 1 | Completed | Celgene | 14 | 2013-07-01 | 2019-11-12 |
| The Effect of Gemfibrozil, Ketoconazole and Clarithromycin on the Amount of LY2409021 in the Bloodstream LY2409021, Gemfibrozil, Ketoconazole - Healthy Volunteers | Phase 1 | Completed | Eli Lilly and Company | 30 | 2013-05-01 | 2019-03-08 |
| GSK239512 DDI Study GSK239512, ketoconazole - Multiple Sclerosis | Phase 1 | Completed | GlaxoSmithKline | 22 | 2013-01-07 | 2017-07-26 |
| Drug-drug Interaction Trial of BI 113608 in Combination With Ketoconazole and Voriconazole in Healthy Male Subjects BI 113608, Ketoconazole, Voriconazole - Healthy | Phase 1 | Completed | Boehringer Ingelheim | 20 | 2013-01-01 | 2017-03-15 |
| Study To Determine The Effect Of Food And Strong CYP3A4 Enzyme Inhibitor On PF-04449913 Drug Levels PF-04449913, ketoconazole - Healthy Volunteers | Phase 1 | Completed | Pfizer | 14 | 2012-12-01 | 2013-04-10 |
| Phase I Study to Assess the Effect on Healthy Male Volunteers of Ketoconazole on the Pharmacokinetics of a Single Dose of AZD5069 Administered Orally. AZD5069, Ketoconazole - Asthma,, Pharmacokinetics, | Phase 1 | Completed | AstraZeneca | 15 | 2012-12-01 | 2015-06-25 |
| Identification and Evaluation of Endogenous Markers for the Assessment of CYP3A Activity Midazolam, Ketoconazole, Rifampicin - Healthy | Phase 1 | Completed | Seoul National University Hospital | 16 | 2012-12-01 | 2014-05-26 |
| Effect of Ketoconazole on Sufentanil NanoTab Pharmacokinetics Sufentanil NanoTab (SUF NT) 15 mcg, Ketoconazole 400 mg, sufentanil NanoTab (SUF NT) 15 mcg - Pharmacokinetics | Phase 1 | Completed | Talphera, Inc | 19 | 2012-11-01 | 2016-11-04 |
| Effect of Ketoconazole on the Pharmacokinetics of JNJ-38518168 in Healthy Volunteers JNJ-38518168 3 mg, JNJ-38518168 30 mg, JNJ-38518168 10 mg - Healthy | Phase 1 | Completed | Janssen Research & Development, LLC | 33 | 2012-10-01 | 2013-07-16 |
| Bioavailability of BI 144807 Given Alone and in Combination With Ketoconazole in Healthy Male Volunteers Ketoconazole, BI 144807 - Healthy | Phase 1 | Completed | Boehringer Ingelheim | 24 | 2012-10-01 | 2013-05-16 |
| A Pharmacokinetics Study of the Effects of GSK2118436 on Warfarin, the Effects of Ketoconazole and Gemfibrozil on GSK2118436, and the Effects of Repeat Doses of GSK2118436 in Subjects With BRAF Mutant Solid Tumors Warfarin, Ketoconazole, Gemfibrozil - Cancer | Phase 1 | Completed | GlaxoSmithKline | 48 | 2012-09-03 | 2017-11-13 |
Showing 20 of 93. Sign in to see all of them.
Neoplasms (7) · Lymphoma (4) · Alzheimer Disease (2) · Asthma (2) · Diabetes Mellitus, Type 2 (2) · Hepatitis C (2) · Lymphoma, Non-Hodgkin (2) · Nausea (2) · Neuroblastoma (2) · Prostatic Neoplasms (2) · Pulmonary Disease, Chronic Obstructive (2) · Recurrence (2) · Vomiting (2) · Autoimmune Diseases (1) · Bacterial Infections (1)
GlaxoSmithKline (14) · Boehringer Ingelheim (6) · AstraZeneca (5) · Pfizer (5) · Abbott (4) · Hoffmann-La Roche (4) · Janssen Research & Development, LLC (4) · Celgene (3) · Eli Lilly and Company (3) · Astellas Pharma Inc (2) · Bristol-Myers Squibb (2) · Genentech, Inc. (2) · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (2) · National Cancer Institute (NCI) (2) · Roswell Park Cancer Institute (2)
United States (58) · United Kingdom (8) · Germany (5) · South Korea (5) · Australia (4) · Belgium (3) · France (2) · Netherlands (2) · Spain (1) · Sweden (1)
Anthony R Godfrey, Pharm.D. (1) · Barry J Maurer, MD, PhD (1) · Barry J. Maurer, MD, PhD (1) · Bengt Larsson, Dr. (1) · Bo Fransson, MD (1) · Brendan Smyth (1)
PMID 18451235, PMID 21480191, PMID 21642470, PMID 22174351, PMID 22393898, PMID 22510871, PMID 22534255, PMID 22845044, PMID 23750331, PMID 23754575, PMID 24417786, PMID 25047497, PMID 25100135, PMID 26381275, PMID 26872892, PMID 27317471, PMID 27859472, PMID 28783865, PMID 28800141, PMID 29500603, PMID 29856004
2009 (2), 2008 (1), P01CA081403 (1), P30CA013330 (1), P30CA014520 (1), P30CA016056 (1), U01CA062491 (1)